ArticleMedicine2019

A pilot safety study of ublituximab, a monoclonal antibody against CD20, in acute relapses of neuromyelitis optica spectrum disorder.

Maureen A Mealy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.